6M40 image
Deposition Date 2020-03-05
Release Date 2020-04-08
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6M40
Keywords:
Title:
Crystal structure of the NS3-like helicase from Alongshan virus
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.89 Å
R-Value Free:
0.29
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:NS3-like protein
Chain IDs:A
Chain Length:489
Number of Molecules:1
Biological Source:Alongshan virus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET modified residue
Ligand Molecules
Primary Citation
Crystal structure of the NS3-like helicase from Alongshan virus.
Iucrj 7 375 382 (2020)
PMID: 32431821 DOI: 10.1107/S2052252520003632

Abstact

Alongshan virus (ALSV) is an emerging human pathogen that was identified in China and rapidly spread to the European continent in 2019, raising concerns about public health. ALSV belongs to the distinct Jingmenvirus group within the Flaviviridae family with segmented RNA genomes. While segments 2 and 4 of the ALSV genome encode the VP1-VP3 proteins of unknown origin, segments 1 and 3 encode the NS2b-NS3 and NS5 proteins, which are related to Flavivirus nonstructural proteins, suggesting an evolutionary link between segmented and unsegmented viruses within the Flaviviridae family. Here, the enzymatic activity of the ALSV NS3-like helicase (NS3-Hel) was characterized and its crystal structure was determined to 2.9 Å resolution. ALSV NS3-Hel exhibits an ATPase activity that is comparable to those measured for Flavivirus NS3 helicases. The structure of ALSV NS3-Hel exhibits an overall fold similar to those of Flavivirus NS3 helicases. Despite the limited amino-acid sequence identity between ALSV NS3-Hel and Flavivirus NS3 helicases, structural features at the ATPase active site and the RNA-binding groove remain conserved in ALSV NS3-Hel. These findings provide a structural framework for drug design and suggest the possibility of developing a broad-spectrum antiviral drug against both Flavivirus and Jingmenvirus.

Legend

Protein

Chemical

Disease

Primary Citation of related structures